TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.

导出 OA

翻译打印收藏纠错

作者： Dhriti,Kaushik ^[1] ; Ranjana,Bhandari ^[2] ; Anurag,Kuhad ^[3]

作者单位： Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Punjab University, Chandigarh India. ^[1] Assistant Professor of Pharmaceutics, University Institute of Pharmaceutical Sciences UGC-Centre of Advanced Study, Panjab University, Chandigarh, India. ^[2] Assistant Professor of Pharmacology, University Institute of Pharmaceutical Sciences UGC-Centre of Advanced Study, Panjab University, Chandigarh, India. ^[3]

关键词 Sars-cov-2 acute respiratory distress syndrome coronavirus covid-19 cytokine storm neurological complications tlr-4 toll-like receptors

主题词动物(Animals);抗病毒药(Antiviral Agents);人类(Humans);肺疾病(Lung Diseases);神经系统疾病(Nervous System Diseases);回顾性研究(Retrospective Studies);Toll样受体4(Toll-Like Receptor 4)

DOI 10.1080/14728222.2021.1918103

PMID 33857397

发布时间 2024-09-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交